Presentation is loading. Please wait.

Presentation is loading. Please wait.

Peripheral Neuropathy Victor F. Politi, M.D., Medical Director, St. Anthonys School of Allied Health Professions, Physician Assistant Program.

Similar presentations

Presentation on theme: "Peripheral Neuropathy Victor F. Politi, M.D., Medical Director, St. Anthonys School of Allied Health Professions, Physician Assistant Program."— Presentation transcript:

1 Peripheral Neuropathy Victor F. Politi, M.D., Medical Director, St. Anthonys School of Allied Health Professions, Physician Assistant Program

2 Introduction Peripheral neuropathy describes damage to the peripheral nervous system. More than 100 types of peripheral neuropathy have been identified, each with its own characteristic set of symptoms, pattern of development, and prognosis.

3 Impaired function and symptoms depend on the type of nerves –motor, sensory, or autonomic that are damaged. Introduction

4 Motor nerves –control movements of all muscles under conscious control, such as those used for walking, grasping things, or talking. Sensory nerves –transmit information about sensory experiences, such as the feeling of a light touch or the pain resulting from a cut. Autonomic nerves –regulate biological activities that people do not control consciously, such as breathing, digesting food, and heart and gland functions. Introduction

5 Although some neuropathies may affect all three types of nerves, others primarily affect one or two types. –Therefore, terms such as predominately motor neuropathy predominately sensory neuropathy sensory-motor neuropathy autonomic neuropathy –are often used to describe a patient's condition. Introduction

6 Because every peripheral nerve has a highly specialized function in a specific part of the body, a wide array of symptoms can occur when nerves are damaged. Some people may experience temporary numbness, tingling, and pricking sensations (paresthesia), sensitivity to touch, or muscle weakness. Introduction

7 Others may suffer more extreme symptoms, including burning pain (especially at night), muscle wasting, paralysis, or organ or gland dysfunction. Introduction

8 People may become unable to digest food easily, maintain safe levels of blood pressure, sweat normally, or experience normal sexual function. In the most extreme cases, breathing may become difficult or organ failure may occur. Introduction

9 Some forms of neuropathy involve damage to only one nerve and are called mononeuropathies. More often though, multiple nerves affecting all limbs are affected-called polyneuropathy. Introduction

10 Occasionally, two or more isolated nerves in separate areas of the body are affected- called mononeuritis multiplex. Introduction

11 In acute neuropathies, such as Guillain- Barré syndrome, symptoms appear suddenly, progress rapidly, and resolve slowly as damaged nerves heal. In chronic forms, symptoms begin subtly and progress slowly. Introduction

12 Some people may have periods of relief followed by relapse. Others may reach a plateau stage where symptoms stay the same for many months or years. Introduction

13 Some chronic neuropathies worsen over time, but very few forms prove fatal unless complicated by other diseases. Occasionally the neuropathy is a symptom of another disorder. Introduction

14 In the most common forms of polyneuropathy, the nerve fibers most distant from the brain and the spinal cord malfunction first. Pain and other symptoms often appear symmetrically, for example, in both feet followed by a gradual progression up both legs. Introduction

15 Next, the fingers, hands, and arms may become affected, and symptoms can progress into the central part of the body. Many people with diabetic neuropathy experience this pattern of ascending nerve damage.

16 Anatomy The bodys nervous system is made up of two parts. –The central nervous system (CNS) –The peripheral nervous system (PNS)

17 Anatomy The peripheral nerves include: –cranial nerves (with the exception of the second) –spinal nerve roots –dorsal root ganglia –peripheral nerve trunks and their terminal branches –peripheral autonomic nervous system

18 Diagnostic Approach The differential diagnosis of peripheral neuropathy is significantly narrowed by a focused clinical assessment that addresses several key issues – –Does the patient actually have a neuropathy? –What is the pattern of involvement? –Is the neuropathy focal, multifocal or symmetric? –If the neuropathy is symmetric, is it proximal or distal?

19 Does the patient actually have a neuropathy? –Causes of generalized weakness include motor neuron disease, disorders of the neuromuscular junction and myopathy. –Peripheral neuropathy can also be mimicked by myelopathy, syringomyelia or dorsal column disorders, such as tabes dorsalis. –Hysterical symptoms can sometimes mimic a neuropathy. Diagnostic Approach

20 Is the neuropathy focal, multifocal or symmetric? –Focal neuropathies include common compressive neuropathies such as carpal tunnel syndrome, ulnar neuropathy at the elbow or peroneal neuropathy at the fibular head –A multifocal neuropathy suggests a mononeuritis multiplex that may be caused, for example, by vasculitis or diabetes Diagnostic Approach

21 If the neuropathy is symmetric, is it proximal or distal? –Most toxic and metabolic neuropathies present as a distal symmetric or dying-back process. –Proximal sensory neuropathies are rare and include porphyria. –Predominantly motor neuropathies are often proximal and include acquired inflammatory neuropathies such as Guillain-Barré syndrome. An exception is lead neuropathy, which initially affects motor fibers in radial and peroneal distributions. Diagnostic Approach

22 Distal Symmetric Sensorimotor Polyneuropathies Infectious diseases –Acquired immunodeficiency syndrome –Lyme disease Sarcoidosis Toxic neuropathy –Acrylamide –Carbon disulfide –Dichlorophenoxyacetic acid –Ethylene oxide –Hexacarbons –Carbon monoxide –Organophosphorus esters –Glue sniffing Metal neuropathy –Chronic arsenic intoxication –Mercury –Gold –Thallium Medications (see next slide)

23 Medications Causing Neuropathies Axonal Vincristine (Oncovin, Vincosar PFS) Paclitaxel (Taxol) Nitrous oxide Colchicine (Probenecid, Col- Probenecid) Isoniazid (Laniazid) Hydralazine (Apresoline) Metronidazole (Flagyl) Pyridoxine (Nestrex, Beesix) Didanosine (Videx) Lithium Alfa interferon (Roferon-A, Intron A, Alferon N) Dapsone Axonal - continued.. Phenytoin (Dilantin) Cimetidine (Tagamet) Disulfiram (Antabuse) Chloroquine (Aralen) Ethambutol (Myambutol) Amitriptyline (Elavil, Endep) Demyelinating Amiodarone (Cordarone) Chloroquine Suramin (Fourneau 309, Bayer 205, Germanin) Gold Neuronopathy Thalidomide (Synovir) Cisplatin (Platinol) Pyridoxine

24 Proximal Symmetric Motor Polyneuropathies –Guillain-Barré syndrome –Chronic inflammatory demyelinating polyradiculoneuropathy –Diabetes mellitus –Porphyria –Osteosclerotic myeloma –Waldenstrom's macroglobulinemia –Monoclonal gammopathy of undetermined significance –Acute arsenic polyneuropathy –Lymphoma –Diphtheria –HIV/AIDS –Lyme disease –Hypothyroidism –Vincristine (Oncovin, Vincosar PFS) toxicity

25 Neuropathies can be categorized according to the fiber type that is primarily involved. Most toxic and metabolic neuropathies are initially sensory and later may involve the motor fibers. Diagnostic Approach

26 Pure sensory neuropathies can result from drug toxicity (e.g., thalidomide, cisplatin [Platinol]), paraneoplastic syndromes or nutritional deficiencies. Primarily motor neuropathies include Guillain-Barré syndrome. Diagnostic Approach

27 Alcoholism and diabetes can both cause small-fiber, painful neuropathies Diagnostic Approach

28 Autonomic involvement occurs in many small-fiber neuropathies but can also occur in Guillain-Barré syndrome and is sometimes life-threatening. Diagnostic Approach

29 It is important to distinguish whether the neuropathy is axonal, demyelinating, or both. This differentiation is best achieved using nerve conduction studies (NCS) and electromyography (EMG). Diagnostic Approach

30 Diabetes, HIV infection and alcoholism can cause several patterns of neuropathy. They most commonly cause a distal, symmetric axonal sensorimotor neuropathy. The second most common presentation in these conditions is a small-fiber, painful neuropathy. Diagnostic Approach

31 History The temporal course of a neuropathy varies, based on the etiology. –With trauma or ischemic infarction, the onset will be acute, with the most severe symptoms at onset. –Inflammatory and some metabolic neuropathies have a subacute course extending over days to weeks. –A chronic course over weeks to months is the hallmark of most toxic and metabolic neuropathies.

32 History A chronic, slowly progressive neuropathy over many years occurs with most hereditary neuropathies or with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neuropathies with a relapsing and remitting course include Guillain-Barré syndrome.

33 Ischemic neuropathies often have pain as a prominent feature. Small-fiber neuropathies often present with burning pain, lightning-like or lancinating pain, aching, or uncomfortable paresthesias (dysesthesias). History

34 Dying-back (distal symmetric axonal) neuropathies initially involve the tips of the toes and progress proximally in a stocking- glove distribution. History

35 Peripheral neuropathy can present as restless leg syndrome. Proximal involvement may result in difficulty climbing stairs, getting out of a chair, lifting and swallowing, and in dysarthria. History

36 The clinical assessment should include: –careful past medical history, looking for systemic diseases that can be associated with neuropathy, such as diabetes or hypothyroidism. History

37 Many medications can cause a peripheral neuropathy, typically a distal symmetric axonal sensorimotor neuropathy. Detailed inquiries about drug and alcohol use, as well as exposure to heavy metals and solvents, should be pursued. History

38 All patients should be questioned regarding –HIV risk factors –foreign travel (leprosy) –diet (nutrition) –vitamin use (especially B6) –possibility of a tick bite (Lyme disease) History

39 The review of systems may provide clues regarding other organ involvement and the presence of an underlying malignancy. History

40 Differential Diagnosis of Neuropathies by Clinical Course Acute onset (within days) Subacute onset (weeks to months) Chronic course/ insidious onset Relapsing/ remitting course Guillain-Barré syndrome Maintained exposure to toxic agents/medications Hereditary motor sensory neuropathies Guillain-Barré syndrome Acute intermittent porphyria Persisting nutritional deficiency Dominantly inherited sensory neuropathy CIDP Critical illness polyneuropathy Abnormal metabolic state CIDPHIV/AIDS Diphtheric neuropathy Paraneoplastic syndrome Toxic Thallium toxicityCIDPPorphyria

41 Physical Examination A cranial nerve examination can provide evidence of mononeuropathies or proximal involvement. Funduscopic examination may show abnormalities such as optic pallor, which can be present in leukodystrophies and vitamin B12 deficiency.

42 Direct strength testing of muscles enervated by cranial nerves V, VII, IX/X, XI and XII is important, as mild bilateral weakness can be missed by observation only. Physical Examination

43 The motor examination includes a search for fasciculations or cramps, or loss of muscle bulk. Tone is normal or reduced. Physical Examination

44 The pattern of weakness helps narrow the diagnosis: symmetric or asymmetric, distal or proximal, and confined to a particular nerve, plexus or root level. Physical Examination

45 Deep tendon reflexes are reduced or absent. A bilateral foot drop may result in a steppage gait in which the patient must lift the knees very high in order to clear the toes. Proximal weakness results in an inability to squat or to rise unassisted from a chair. Physical Examination

46 The general physical examination can provide evidence of orthostatic hypotension without a compensatory rise in heart rate when autonomic fibers are involved. Physical Examination

47 Respiratory rate and vital capacity should be evaluated in Guillain-Barré syndrome to assess for respiratory compromise. The presence of lymphadenopathy, hepatomegaly or splenomegaly, and skin lesions may provide evidence of systemic disease. Physical Examination

48 Pale transverse bands in the nail beds, parallel to the lunula (Mees' lines), suggest arsenic poisoning. Physical Examination

49 Laboratory Evaluation EMG and nerve conduction studies (NCS) are often the most useful initial laboratory studies in the evaluation of a patient with peripheral neuropathy

50 They can confirm the presence of a neuropathy and provide information as to the type of fibers involved (motor, sensory, or both), the pathophysiology (axonal loss versus demyelination) and a symmetric versus asymmetric or multifocal pattern of involvement. Laboratory Evaluation

51 The limitations of EMG/NCS should be taken into account when interpreting the findings. –There is no reliable means of studying proximal sensory nerves. –NCS results can be normal in patients with small-fiber neuropathies –Lower extremity sensory responses can be absent in normal elderly patients. EMG/NCS are not substitutes for a good clinical examination. Laboratory Evaluation

52 Subsequent studies should be tailored to the most likely diagnostic possibilities, and to the acuteness and severity of the neuropathy. With an acute progressive neuropathy, a neurologic consultation early in the course of the evaluation is essential. Further evaluation of these patients includes EMG/NCS, lumbar puncture, chest radiograph, electrocardiogram and determination of forced vital capacity. Laboratory Evaluation

53 The most common presentation is that of a distal symmetric sensorimotor neuropathy. Initial evaluation should include: – fasting serum glucose, glycosylated hemoglobin, blood urea nitrogen, creatinine, complete blood cell count, erythrocyte sedimentation rate, urinalysis, vitamin B12 and thyrotropin stimulating hormone levels. –Neurologic assessment may be warranted if the initial evaluation does not produce a diagnosis. Laboratory Evaluation

54 CSF is useful in evaluation of myelinopathies and polyradiculopathies. An elevated total protein level with < 5 wbc(albuminocytologic dissociation) is present in acquired inflammatory neuropathy (e.g., Guillain-Barré syndrome, CIDP). Laboratory Evaluation

55 Other studies useful in specific clinical contexts are: –cytology (lymphoma) –special studies such as Lyme polymerase chain reaction and cytomegalovirus branched chain DNA (polyradiculopathy or mononeuritis multiplex in AIDS). Laboratory Evaluation

56 Nerve biopsy is only helpful in very specific cases to diagnose vasculitis, leprosy, amyloid neuropathy, leukodystrophies, sarcoidosis and, occasionally, CIDP. Laboratory Evaluation

57 It can be difficult to document a small-fiber neuropathy because the only abnormalities on neurologic examination may be loss of pinprick and temperature sensation in a distal distribution. Laboratory Evaluation

58 EMG/NCS may be normal. Autonomic studies are only helpful if the autonomic fibers are involved. As a result, small-fiber neuropathy remains a primarily clinical diagnosis. Laboratory Evaluation

59 The evaluation should include the most likely causes (i.e., diabetes, alcoholism, AIDS). If these studies are normal, a neurologic consultation is recommended. Laboratory Evaluation

60 Treatment The goal of treatment is to manage the underlying condition causing the neuropathy and repair damage, as well as provide symptom relief.

61 Treatment Controlling a chronic condition may not eliminate the neuropathy, but it can play a key role in managing it.

62 Treatment Neuropathic pain is often difficult to control. Medications : –OTC analgesics. –antiepileptic drugs, including gabapentin, phenytoin, and carbamazepine –some classes of antidepressants, including tricyclics such as amitriptyline. –Mexiletine –local anesthetics such as lidocaine or topical patches containing lidocaine –Codeine/oxycodone

63 Mechanical aids can help reduce pain and lessen the impact of physical disability. –Hand or foot braces can compensate for muscle weakness or alleviate nerve compression. –Orthopedic shoes can improve gait disturbances and help prevent foot injuries in people with a loss of pain sensation. If breathing becomes severely impaired, mechanical ventilation can provide essential life support. Treatment

64 Surgical intervention often can provide immediate relief from mononeuropathies caused by compression or entrapment injuries. –Repair of a slipped disk can reduce pressure on nerves where they emerge from the spinal cord; the removal of benign or malignant tumors can also alleviate damaging pressure on nerves. –Nerve entrapment often can be corrected by the surgical release of ligaments or tendons. Treatment

65 Questions ???

Download ppt "Peripheral Neuropathy Victor F. Politi, M.D., Medical Director, St. Anthonys School of Allied Health Professions, Physician Assistant Program."

Similar presentations

Ads by Google